Anthropic Says Claude Found CRISPR-Like Enzyme System in Phage DNA
United States
Carlos Barria/Reuters
Source Analysis
What Happened
Key Implications
What Happened
Key Implications
Where Sources Agree
- arrows_inputAI-Led Enzyme Discovery: Coverage broadly notes that Anthropic’s Claude AI identified a novel enzyme system named array-associated reverse transcriptases (ART) within bacteriophage DNA, which exhibits repeating sequences reminiscent of the CRISPR gene-editing tool, according to company statements and research preprints.
- arrows_inputAI-Driven Biological Discovery: Coverage highlights the deployment of 950 Claude agents to identify a novel enzyme system in bacteriophage DNA, framing it as a significant demonstration of AI-accelerated biological research, per Anthropic company statements.
- arrows_inputLab Safety and Oversight: Outlets concur on the safety protocols and operational scope of Anthropic's Bay Area lab, per the company, which operates at BSL-1 and BSL-2 levels, does not handle human pathogens, and relies exclusively on human scientists for all wet-lab experiments.
Where Sources Disagree
- arrows_outputART System Significance: Anthropic suggests the newly discovered 'ART' enzyme system could represent a new, programmable gene editing mechanism akin to CRISPR. However, some microbiologists argue there is currently no evidence indicating the system is a rival to existing CRISPR technology or that it holds immediate therapeutic potential.
- arrows_outputDiscovery Novelty: While Anthropic touts Claude’s identification of a 'previously unknown' enzyme system as a novel breakthrough, the company’s leadership acknowledges that a Stanford team had previously described a comparable—albeit distinct—system.
Timeline
September 24, 2026
Function unknown; cautious framing: Anthropic and outside scientists emphasized that ART's precise function and biotechnological utility remain unknown, that humans designed the search and carried out experiments, and that further work is required to determine whether ART is truly a new gene‑editing mechanism.
September 24, 2026
External reactions and lab details: Anthropic acknowledged a Stanford team had independently described a comparable system, CRISPR pioneer Feng Zhang called the RNA-repeat arrays "intriguing," and the company confirmed its Bay Area lab (formed this spring) operates at BSL‑1/2 and does not handle human pathogens.
September 24, 2026
Laboratory tests and preprint: Human researchers in Anthropic's lab performed follow-up experiments that showed the repeating DNA array produces distinct short RNAs and reported initial tests suggesting the system could be programmable; the results were released as a preprint that has not yet been peer reviewed.
Perspectives and Debates
How significant is the ART discovery for gene editing and biology?
Summary by Ground AI
Sources
See All 103A varied selection of sources chosen by Ground to reflect the diversity of this story’s coverage.
Most Written About
The stories getting the most coverage from the last 24 hours
Source Analysis
Timeline
September 24, 2026
Function unknown; cautious framing: Anthropic and outside scientists emphasized that ART's precise function and biotechnological utility remain unknown, that humans designed the search and carried out experiments, and that further work is required to determine whether ART is truly a new gene‑editing mechanism.
September 24, 2026
External reactions and lab details: Anthropic acknowledged a Stanford team had independently described a comparable system, CRISPR pioneer Feng Zhang called the RNA-repeat arrays "intriguing," and the company confirmed its Bay Area lab (formed this spring) operates at BSL‑1/2 and does not handle human pathogens.
September 24, 2026
Laboratory tests and preprint: Human researchers in Anthropic's lab performed follow-up experiments that showed the repeating DNA array produces distinct short RNAs and reported initial tests suggesting the system could be programmable; the results were released as a preprint that has not yet been peer reviewed.
